Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BIOBIO-B Insider Trading

BIOBIO-B | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BIOBIO-B provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-11-11 00:15 2025-11-06 BARRY JAMES Officer - EVP, President, LSG SELL $306.18 700 $214,289 510 -57.9%
2025-03-18 23:36 2025-03-14 Crowley Michael Officer - EVP, GBL Commercial Operations OPT+S $247.06 3,000 $741,184 8,171 0.0%
2014-12-13 03:58 2014-12-12 Magni Giovanni Officer - EVP, Chief Strategy Officer OPT+S $117.38 5,000 $586,900 11,811 0.0%
2014-11-15 03:15 2014-11-13 SCHWARTZ STEVEN D 10% owner SELL $111.93 530 $59,323 1,818 -22.6%
2012-12-07 23:15 2012-12-06 Magni Giovanni Officer - Vice President, Intl Sales OPT+S $103.88 5,605 $582,262 7,988 0.0%
2012-06-13 22:08 2012-06-12 TSINGOS CHRISTINE A Officer - CFO SELL $96.51 74 $7,142 3,563 -2.0%
2012-06-13 22:02 2012-06-12 STARK JAMES R Officer - Controller SELL $96.51 74 $7,142 2,207 -3.2%
2012-06-13 21:52 2012-06-12 Magni Giovanni Officer - Vice President, Intl Sales SELL $96.51 87 $8,396 7,600 -1.1%
2012-06-13 21:35 2012-06-12 CRUTCHFIELD BRADFORD Officer - Vice President SELL $96.51 87 $8,396 5,875 -1.5%
2011-06-16 01:08 2011-06-14 WADLER SANFORD Officer - VP, General Counsel, Secretary SELL $117.53 75 $8,815 11,811 -0.6%
2011-06-15 21:49 2011-06-14 Magni Giovanni Officer - Vice President, Intl Sales SELL $117.53 87 $10,225 7,386 -1.2%
2011-06-15 21:21 2011-06-14 TSINGOS CHRISTINE A Officer - CFO SELL $117.53 75 $8,815 3,386 -2.2%
2011-06-15 21:19 2011-06-14 STARK JAMES R Officer - Controller SELL $117.53 75 $8,815 2,030 -3.6%
2011-06-15 21:18 2011-06-14 HUTTON RONALD W Officer - Treasurer SELL $117.53 50 $5,877 844 -5.6%
2011-06-15 21:15 2011-06-14 CRUTCHFIELD BRADFORD Officer - Vice President SELL $117.53 87 $10,225 5,751 -1.5%
2011-03-12 03:44 2011-03-11 GOETZ JOHN Officer - Vice President SELL $115.63 3,000 $346,903 35,532 -7.8%
2011-03-09 02:32 2011-03-08 HUTTON RONALD W Officer - Treasurer OPT+S $117.91 2,320 $273,541 798 0.0%
2011-03-09 02:01 2011-03-07 Magni Giovanni Officer - Vice President, Intl Sales OPT+S $115.00 6,374 $733,037 7,322 0.0%
2011-03-08 02:11 2011-03-07 STARK JAMES R Officer - Controller OPT+S $114.23 5,000 $571,151 1,979 0.0%
2011-03-07 20:45 2011-03-04 TSINGOS CHRISTINE A Officer - CFO OPT+S $115.50 4,692 $541,926 3,335 0.0%
2011-03-05 03:17 2011-03-04 Magni Giovanni Officer - Vice President, Intl Sales OPT+S $117.00 626 $73,242 7,322 0.0%
2011-03-04 21:00 2011-03-03 SCHWARTZ STEVEN D 10% owner SELL $116.62 216 $25,189 2,348 -8.4%
2011-03-04 01:43 2011-03-03 HUTTON RONALD W Officer - Treasurer SELL $116.30 1,032 $120,057 798 -56.4%
2011-03-03 22:34 2011-03-02 CRUTCHFIELD BRADFORD Officer - Vice President OPT+S $113.01 4,000 $452,045 5,418 0.0%
2011-03-03 22:09 2011-03-01 WADLER SANFORD Officer - VP, General Counsel, Secretary OPT+S $113.85 8,946 $1,018,517 11,760 0.0%
2010-11-23 01:20 2010-11-19 BENNETT JAMES Director SELL $95.07 4,020 $382,167 32,546 -11.0%
2010-11-19 02:50 2010-11-18 TSINGOS CHRISTINE A Officer - CFO OPT+S $95.03 9,000 $855,262 3,335 0.0%
2010-11-18 04:14 2010-11-17 Magni Giovanni Officer - Vice President, Intl Sales SELL $94.01 2,500 $235,021 7,322 -25.5%
SHOW ENTRIES
1-28 OF 28

How to Interpret $BIOBIO-B Trades

Not every insider transaction in BIOBIO-B is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BIOBIO-B shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BIOBIO-B

Insider activity data for BIOBIO-B is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BIOBIO-B, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.